Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Longboard Pharmaceuticals, Inc. (LBPH) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Longboard Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1832168.
Total stock buying since 2024: $2,482.
Total stock sales since 2024: $98,586,507.
Total stock option exercises since 2024: $742,871.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 100 | $2,482 | 4,028,640 | $98,586,507 | 175,844 | $742,871 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-11 | 0 | $0 | 0 | $0 | 43,362 | $223,323 |
| 2024-10 | 0 | $0 | 16,667 | $983,936 | 16,667 | $72,501 |
| 2024-09 | 0 | $0 | 16,666 | $541,061 | 16,666 | $72,497 |
| 2024-08 | 0 | $0 | 16,667 | $579,828 | 99,149 | $374,550 |
| 2024-06 | 0 | $0 | 100 | $2,087 | 0 | $0 |
| 2024-01 | 100 | $2,482 | 3,978,540 | $96,479,595 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-19 | Kaye Randall (CMO) | Option Ex | 30,554 | 6.00 | 183,324 |
| 2024-11-13 | Lind Kevin Robert (CEO) | Option Ex | 12,808 | 3.12 | 39,999 |
| 2024-10-15 | Kaye Randall (CMO) | Sale | 16,667 | 59.03 | 983,936 |
| 2024-10-15 | Kaye Randall (CMO) | Option Ex | 16,667 | 4.35 | 72,501 |
| 2024-09-16 | Kaye Randall (CMO) | Sale | 16,666 | 32.47 | 541,061 |
| 2024-09-16 | Kaye Randall (CMO) | Option Ex | 16,666 | 4.35 | 72,497 |
| 2024-08-12 | Lind Kevin Robert (CEO) | Option Ex | 82,482 | 3.66 | 302,049 |
| 2024-08-12 | Kaye Randall (CMO) | Sale | 16,667 | 34.79 | 579,828 |
| 2024-08-12 | Kaye Randall (CMO) | Option Ex | 16,667 | 4.35 | 72,501 |
| 2024-06-25 | Kaye Randall (CMO) | Sale | 100 | 20.87 | 2,087 |
| 2024-01-25 | Arena Pharmaceuticals Inc (Other) | Sale | 3,978,540 | 24.25 | 96,479,595 |
| 2024-01-23 | Kaye Randall (CMO) | Buy | 100 | 24.82 | 2,482 |
Insider trading activities including stock purchases, stock sales, and option exercises of LBPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Longboard Pharmaceuticals, Inc. (symbol LBPH, CIK number 1832168) see the Securities and Exchange Commission (SEC) website.